This inventor holds 1 USPTO granted patent. Top assignee: Suntory Limited. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: The Innovations of Atsuto Ogata
Introduction
Atsuto Ogata is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of intermittent claudication. His innovative approach has led to the development of therapeutic drugs that utilize pyrroloazepines.
Latest Patents
Atsuto Ogata holds a patent for a method of treating or improving intermittent claudication. This patent, titled "Intermittent claudication therapeutic drugs comprising pyrroloazepines," involves administering a pyrroloazepine derivative or a pharmacologically acceptable salt to patients suffering from this condition. The patent represents a significant advancement in therapeutic options for individuals affected by intermittent claudication. He has 1 patent to his name.
Career Highlights
Ogata is currently employed at Suntory Limited, a well-respected company known for its contributions to various industries, including pharmaceuticals. His work at Suntory has allowed him to focus on innovative solutions that address critical health issues.
Collaborations
Some of his notable coworkers include Akira Mizuno and Norio Inomata. Their collaborative efforts have contributed to the advancement of research and development in their respective fields.
Conclusion
Atsuto Ogata's work exemplifies the impact of innovation in medicine, particularly through his patent for treating intermittent claudication. His contributions continue to influence the pharmaceutical landscape, showcasing the importance of research and collaboration in developing effective treatments.